AAAAAA
Results:
1-8
|
Results: 8
Authors:
Haroldson, JA
Somerville, KT
Carlson, S
Hanson, J
Emery, RW
Lake, KD
Citation: Ja. Haroldson et al., A retrospective assessment of safety, efficacy, and pharmacoeconomics of generic azathioprine in heart-transplant recipients, J HEART LUN, 20(3), 2001, pp. 372-374
Authors:
Arndorfer, JA
Meier-Kriesche, HU
Ojo, AO
Gruber, SA
Cibrik, DM
Lake, KD
Kaplan, B
Leichtman, AB
Citation: Ja. Arndorfer et al., Time to first graft loss as a risk factor for second renal allograft loss, TRANSPLAN P, 33(1-2), 2001, pp. 1188-1189
Authors:
Haroldson, JA
Kramer, LE
Wolff, DL
Lake, KD
Citation: Ja. Haroldson et al., Elevated free fractions of valproic acid in a heart transplant patient with hypoalbuminemia, ANN PHARMAC, 34(2), 2000, pp. 183-187
Authors:
Angaran, DM
Bonal, J
Eide, G
Koda-Kimble, MA
Lake, KD
Leufkens, HGM
Citation: Dm. Angaran et al., Clinical pharmacy: Looking 20 years back ... Looking 20 years forward, PHARMACOTHE, 20(10), 2000, pp. 235S-242S
Authors:
Freitag, VL
Skifton, RD
Lake, KD
Citation: Vl. Freitag et al., Effect of short-term rifampin on stable cyclosporine concentrations, ANN PHARMAC, 33(7-8), 1999, pp. 871-872
Authors:
Wright, DH
Lake, KD
Bruhn, PS
Emery, RW
Citation: Dh. Wright et al., Nefazodone and cyclosporine drug-drug interaction, J HEART LUN, 18(9), 1999, pp. 913-915
Authors:
Lee, J
Lawrence, BJ
Sullivan, SD
Johnson, NE
Barriere, SL
Lake, KD
Stevenson, JG
Citation: J. Lee et al., Guidelines for pharmacoeconomic research fellowships, PHARMACOTHE, 19(9), 1999, pp. 1105-1109
Authors:
Jarai, Z
Wagner, JA
Varga, K
Lake, KD
Compton, DR
Martin, BR
Zimmer, AM
Bonner, TI
Buckley, NE
Mezey, E
Razdan, RK
Zimmer, A
Kunos, G
Citation: Z. Jarai et al., Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors, P NAS US, 96(24), 1999, pp. 14136-14141
Risultati:
1-8
|